What is the recommended laboratory diagnosis for a case of syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Diagnosis for Syphilis

The recommended laboratory diagnosis for syphilis requires both treponemal and non-treponemal tests, with initial screening using either a non-treponemal test (traditional approach) or a treponemal test (reverse sequence approach), followed by confirmation with the other test type. 1

Diagnostic Approaches

Traditional Screening Approach

  • Initial screening with non-treponemal tests:
    • Rapid Plasma Reagin (RPR)
    • Venereal Disease Research Laboratory (VDRL)
  • Confirmation with treponemal tests:
    • T. pallidum particle agglutination (TP-PA)
    • Enzyme immunoassay (EIA)
    • Chemiluminescent immunoassay (CIA) 2, 1

Reverse Sequence Approach

  • Initial screening with treponemal tests (EIA or CIA)
  • Confirmation of active disease with quantitative non-treponemal tests (RPR or VDRL) 2, 1

Test Characteristics

Non-treponemal Tests (RPR, VDRL)

  • Primary Syphilis: Sensitivity 62-78% 2
    • RPR: 62.5-92.7% sensitive
    • VDRL: 50-78.4% sensitive 2, 1
  • Secondary Syphilis: Sensitivity 97-100% 2
    • RPR: 97-100% sensitive
    • VDRL: 100% sensitive 2, 1
  • Early Latent Syphilis:
    • VDRL: 82.1-100% sensitive 2, 1

Treponemal Tests

  • Higher sensitivity (95-100%) and specificity (95-100%) compared to non-treponemal tests 1
  • Include:
    • FTA-ABS (Fluorescent Treponemal Antibody Absorption)
    • TP-PA (T. pallidum Particle Agglutination)
    • EIA (Enzyme Immunoassay)
    • CIA (Chemiluminescent Immunoassay) 1

Test Interpretation

RPR/VDRL Result Treponemal Test Result Interpretation
Positive Positive Confirmed syphilis (current or past)
Positive Negative Likely false-positive RPR/VDRL
Negative Positive Possible very early infection, previously treated syphilis, or late-stage syphilis
Negative Negative No evidence of syphilis [1]

Special Testing Considerations

  • Direct detection methods may be useful for primary syphilis:

    • Darkfield microscopy of lesion exudate
    • PCR testing of lesion material 3
  • Neurosyphilis diagnosis requires:

    • Lumbar puncture with CSF analysis
    • CSF-VDRL (high specificity but limited sensitivity)
    • CSF treponemal tests (interpreted in clinical context) 1
  • Point-of-care testing:

    • Rapid immunochromatographic tests can detect both treponemal and non-treponemal antibodies simultaneously
    • Useful in resource-limited settings or when follow-up is uncertain 4

Common Pitfalls and Caveats

  • False-positive non-treponemal tests can occur in:

    • Pregnancy
    • Autoimmune diseases
    • Viral infections
    • Advanced age
    • Malaria
    • HCV infection
    • Drug use 1
  • Prozone phenomenon: False-negative results in high-titer specimens due to antibody excess; dilution of specimen resolves this issue

  • Serofast state: Persistent low-titer positive non-treponemal tests despite adequate treatment; does not indicate treatment failure

  • Window period: Early primary syphilis may be seronegative; direct detection methods should be used if clinical suspicion is high

Follow-up Testing

  • Monitor treatment response with quantitative non-treponemal testing at 3,6,9, and 12 months
  • A fourfold decline in titer within 6 months indicates successful treatment for primary/secondary syphilis
  • Failure to achieve fourfold decline may indicate treatment failure
  • A fourfold increase after initial decline suggests reinfection 1

The complexity of syphilis serology often requires the expertise of reference laboratories and clinical specialists for proper interpretation, particularly in challenging cases 5.

References

Guideline

Syphilis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

CDC Laboratory Recommendations for Syphilis Testing, United States, 2024.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2024

Research

The laboratory diagnosis of syphilis.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.